Studie - Women's Health Postmenopausal Osteoporosis

Life Science Analytics
04.2008
129 Seiten

 
Typ:
Studie
Verfüg­barkeit:
verfügbar
Regionen/­Länder:
  • Europa
  • Asien / Pazifik
  • Mittlerer Osten / Afrika
  • Nordamerika / USA
  • Australien
  • Mittel- / Südamerika

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

PDF-Datei per E-Mail, versandkostenfrei


Life Science Analytics', 'Women's Health Postmenopausal Osteoporosis ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

• Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
• Keep track of your competitors and partners by better understanding their product pipeline.
• Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
• Maintain a critical competitive advantage.
UPCOMING PATENT EXPIRES BY THERAPY AREA

Postmenopausal Osteoporosis Pipeline Overview

--% of Projects (By Phase of Development)

--No. of Projects by Phase of Development

Company Overview - Pipeline Projects

--Company Overview - Pipeline Projects



--Top Companies in late stage Postmenopausal Osteoporosis Projects

--Amgen Inc

--Barr Pharmaceuticals Inc

--Bone Medical Ltd

--DAIICHI SANKYO COMPANY, LIMITED

--Eli Lilly & Co

--Ligand Pharmaceuticals Inc

--Nastech Pharmaceutical Co Inc

--Par Pharmaceutical Companies Inc

--Pfizer Inc

--SCOLR Pharma Inc

--Wyeth



--Top Companies in early stage Postmenopausal Osteoporosis Projects

--Bionovo Inc

--Eisai Co Ltd

--Radius

--erly NuVios, Inc.)



Pipeline Revenue

--Pipeline Revenue

Full Pipeline View

--Pre Clinical Pipeline View

--Phase II Pipeline View

--Phase III Pipeline View

--Pending Approval Pipeline View

--Post Marketing Pipeline View

--On the Market Pipeline View

--Discovery/Development Pipeline View

* Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

 

Über marktforschung.de

Branchenwissen an zentraler Stelle bündeln und abrufbar machen – das ist das Hauptanliegen von marktforschung.de. Unser breites Informationsangebot rund um die Marktforschung richtet sich sowohl an Marktforschungsinstitute, Felddienstleister, Panelbetreiber und Herausgeber von Studien, Marktdaten sowie Marktanalysen als auch an deren Kunden aus Industrie, Handel und Dienstleistungsgewerbe.

facebook twitter google plus